InvestSMART

PainChek Ltd (ASX: PCK) - Announcements

Current share price for PCK : $0.078 0.008 (11.43%)+

ASX company news and announcements for PainChek Ltd (PCK) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PainChek Ltd (PCK) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PainChek Ltd (PCK), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PainChek Ltd (PCK)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$16 PainChek has productive final FDA De Novo clearance meeting 5 Jun 2025 8:33AM $0.055 $0.078 risen by 41.82%
$16 PainChek partners with Eldermark to expand US market reach 27 May 2025 8:50AM $0.048 $0.078 risen by 62.50%
$16 PainChek appoints head of Business Development for US market 20 May 2025 9:17AM $0.044 $0.078 risen by 77.27%
$16 Notification regarding unquoted securities - PCK 19 May 2025 3:26PM $0.044 $0.078 risen by 77.27%
$16 Notification of cessation of securities - PCK 19 May 2025 3:15PM $0.044 $0.078 risen by 77.27%
$16 Quarterly Investor Presentation April 2025 1 May 2025 8:49AM $0.035 $0.078 risen by 122.86%
$16 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 8:47AM $0.039 $0.078 risen by 102.60%
$16 Quarterly update and Appendix 4C webinar 29 Apr 2025 1:41PM $0.036 $0.078 risen by 116.67%
$16 R&D Tax Refund, FDA Review of Adult App & Infant App Launch 16 Apr 2025 8:44AM $0.035 $0.078 risen by 122.86%
$16 Notification regarding unquoted securities - PCK 27 Mar 2025 11:01AM $0.034 $0.078 risen by 129.41%
$16 Notification regarding unquoted securities - PCK 27 Mar 2025 10:55AM $0.034 $0.078 risen by 129.41%
$16 Application for quotation of securities - PCK 27 Mar 2025 10:50AM $0.034 $0.078 risen by 129.41%
$16 Update to previous announcement 17 Mar 2025 12:42PM $0.029 $0.078 risen by 168.97%
$16 PainChek to present at NWR Virtual Healthcare Conference 17 Mar 2025 9:30AM $0.029 $0.078 risen by 168.97%
$16 Notification regarding unquoted securities - PCK 6 Mar 2025 9:55AM $0.030 $0.078 risen by 160%
$16 Application for quotation of securities - PCK 6 Mar 2025 9:42AM $0.030 $0.078 risen by 160%
$16 Notification regarding unquoted securities - PCK 5 Mar 2025 3:47PM $0.030 $0.078 risen by 164.41%
$16 Half Yearly Report and Accounts 28 Feb 2025 8:09AM $0.032 $0.078 risen by 143.75%
$16 Results of Meeting 26 Feb 2025 4:51PM $0.033 $0.078 risen by 136.36%
$16 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 8:24AM $0.028 $0.078 risen by 178.57%
$16 Quarterly update and Appendix 4C webinar 30 Jan 2025 9:45AM $0.027 $0.078 risen by 188.89%
$16 Notice of General Meeting/Proxy Form 24 Jan 2025 10:28AM $0.027 $0.078 risen by 188.89%
$16 Notification of cessation of securities - PCK 24 Dec 2024 10:54AM $0.026 $0.078 risen by 200%
$16 Change of Director's Interest Notice x5 23 Dec 2024 10:40AM $0.025 $0.078 risen by 212%
$16 Notification regarding unquoted securities - PCK 19 Dec 2024 10:59AM $0.026 $0.078 risen by 200%

101 - 125 of 485 results

Page 5 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.